Tahmineh Safaie

Tahmineh Safaie

Company: Nammi Therapeutics

Job title: Senior Associate Scientist


Novel Vehicles for Tumor Delivery of Immune-modulating Prodrug Combinations 2:00 pm

• Nammisome advantages in tackling the challenges of immunotherapies • SLNP-IC1 Nammisome: An improved Doxil ® with better stability, efficacy, and safety • Introducing NTI-121: An example of using the Nammisomes as a platform for the combination of a Doxorubicin prodrug and a TLR7 agonist prodrugRead more

day: Day One Track B PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.